Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
How-To Geek on MSN
Stop typing the same 4 commands: How a simple Python script saves me time every day
Learn how to automate your Git workflow and environment variables into a single, error-proof command that handles the boring stuff for you.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results